作者: Frank Himmelsbach , Birgit Jung
DOI:
关键词:
摘要: The present invention relates to novel pharmaceutical compositions comprising at least one EGFR kinase inhibitor and additional active compound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP NK1 antagonists endothelin-antagonists, processes for preparing the use thereof as medicament in treatment of respiratory or gastrointestinal complaints, well inflammatory diseases joints, skin eyes.